Published in Healthcare Mergers, Acquisitions and Ventures Week, April 21st, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Memorial Sloan-Kettering Cancer Center, New York City, U.S.
Report 1: Researchers led by scientists at Memorial Sloan-Kettering Cancer Center have identified fundamentally novel regulatory mechanisms of PTEN function. The findings from two related studies are published Cell.
PTEN is one of the most commonly mutated tumor suppressor genes. It is an antagonist for many cellular growth, proliferation and survival processes....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.